Buyer guide

Best pharma paid social agencies and how to choose one

The best pharma paid social agency is the one that can run your Meta and X campaigns inside your medical, legal and regulatory review. Firms to put on a shortlist include Be Leaded, Klick Health, EVERSANA INTOUCH, Fingerpaint Group, Real Chemistry and CMI Media Group.

The shortlist at a glance

Pharma brand teams usually hire for paid social in one of three ways. Some want a large commercialization network that can also handle creative, market access and medical writing. Some want a health media agency that plans and buys across many channels. Others want a focused paid social partner that lives inside Meta and X every day and plugs into the review process the brand already runs. Each firm below sits mostly in one of those groups.

  • Be Leaded: a focused paid social partner for pharma brand teams, with approvals at the center of the workflow
  • Klick Health: a health-only commercialization partner with medical, regulatory, creative and tech under one roof
  • EVERSANA INTOUCH: an agency network inside EVERSANA with a media unit and a services list that names social media
  • Fingerpaint Group: an agency group whose practices include Media & Activation alongside marketing and medical communications
  • Real Chemistry: a healthcare-only network whose Media & Influence practice covers social, creator and paid media
  • CMI Media Group: the healthcare-only media agency within WPP, working across patient, caregiver and HCP audiences
  • Also worth a look: PHM, Underscore, Butler/Till, Supreme Optimization and Cardinal Digital Marketing

Read the list as a set of options rather than a ranking. No public source ranks these firms on paid social alone, so we have not put numbers next to any name.

How we put this list together

We opened each firm's own website on November 17, 2026 and wrote down only what that site says about the firm's services, structure and audiences. Where a site does not mention paid social directly, we say so instead of filling the gap. We left out client results, award counts and spend figures for other firms because buyers should hear those from the firms themselves, in a pitch, with context.

Be Leaded appears first because we wrote this guide and we want you to know where we stand before you read anything else. Everything we say about our own work sits in one clearly marked paragraph. The rest of the page is meant to help you choose, even if the answer is somebody else.

Sites change. Before you sign anything, open the current pages yourself and ask each firm to confirm who would run your account and how social media is staffed.

Be Leaded

Be Leaded is a US agency that runs paid social for pharmaceutical brand teams. We plan audiences, build the ads and any landing pages or forms and submit to a platform only the versions your medical, legal and regulatory reviewers have signed off. If a later change is needed, it goes back through the same review.

Our team manages $100M in annual ad spend and has over a decade of experience running paid social for big pharma brands on Meta, X and other platforms.

We fit brand teams that want a partner focused on paid social rather than a full commercialization network. If you also need market access, medical writing or a large creative studio, one of the networks below may suit you better, and we will tell you that on a call.

Before we propose anything, we ask which campaign type you have in mind, which people the ads must reach, which markets matter and how your reviewers work. The rules that apply to pharma ads on social media shape every one of those answers, so we start there.

Klick Health

Klick describes itself as a partner that helps life sciences companies commercialize their products and improve their commercial operations. Its homepage says the firm works only in health and that its medical, science, regulatory, brand, creative and tech functions are tightly integrated. It also points to its own data models as part of how it works (klick.com).

The homepage does not list paid social as its own line item. If social media is the main thing you are buying, ask Klick which group would plan and buy it, who writes the ads and how its in-house regulatory people work with your reviewers.

Klick tends to suit a brand that wants one partner across a large share of commercial work, where paid social is one channel among many.

EVERSANA INTOUCH

EVERSANA INTOUCH is the agency network inside EVERSANA. Its site lists separate units for global marketing, medical communications, market access and media, and its services menu includes brand planning, omnichannel activation and a line for media and social media (eversanaintouch.com).

The parent company, EVERSANA, sells commercialization models for launching products, direct-to-patient programs, oncology and established brands, along with data and AI tools (eversana.com). That matters if you want your social media plan connected to patient services or access work that the same company already runs for you.

Ask how the media unit and the social team share data with the rest of the network, and whether you can buy paid social on its own or only as part of a wider package.

Fingerpaint Group

Fingerpaint Group calls itself a collection of people and expertise across life science solutions. Its site lists practices for marketing, multicultural work, media and activation, branding, market access, medical affairs and medical communications. It says it partners with pharma, biotech, medical device and animal health companies. The group was founded in Saratoga Springs, New York, in 2008 and is headquartered in Cedar Knolls, New Jersey (fingerpaint.com).

For a paid social buyer the Media & Activation practice is the part to probe. Ask whether social buying sits inside that practice, which platforms the team runs directly and how it hands creative between the marketing and media groups.

Real Chemistry

Real Chemistry presents itself as a healthcare-only partner built around five practices: Advertising, Analytics & Insights, Integrated Communications, Media & Influence and Medical Communications. It describes Media & Influence as audience-led omnichannel strategy, with social, creator and paid media working together (realchemistry.com).

That mix fits a brand that wants paid social to run next to creators, earned media and influencer programs. If you only need paid placements, ask how the firm would scope a smaller engagement and who would sit on it day to day.

CMI Media Group

CMI Media Group describes itself as WPP's dedicated healthcare-only media agency. Its homepage talks about strategy, media, audience intelligence and performance work for pharmaceutical and life sciences brands, across patient, caregiver and HCP audiences, and across both DTC and HCP engagement (cmimediagroup.com).

A holding company media agency can bring buying scale and data partnerships. The tradeoff to test is attention. Ask how many people would work on your social campaigns, how often they change and what your brand would need to spend to get senior time.

Other firms to consider

PHM

PHM is the health media agency in the Publicis family. Its footer names Publicis Health Media, and its homepage frames the work around search, signal, platforms and partnerships (publicishealthmedia.com). It is a natural option if your brand already uses Publicis creative agencies.

Underscore

Underscore says it is a media agency for biopharma teams with complex launches, built only for rare disease and oncology, with a senior team on every account (underscoremarketing.com). Consider it when your audience is a small group of prescribers and patients who are hard to find.

Butler/Till

Butler/Till describes itself as women-owned and led and fully employee-owned. Its services cover media, campaign analytics and marketing science, creative and in-house technology, and it runs a healthcare practice (butlertill.com).

Supreme Optimization

Supreme Optimization runs paid social for life science and healthcare companies. Its paid social page describes campaigns planned by Ph.D. scientist marketers, LinkedIn targeting by scientific skills and Meta audience expansion to B2B, HCP and patient audiences (supremeopti.com). Its published examples lean toward research tools and biotech buyers. The same page also describes Meta campaigns for HCP and patient audiences, so ask how much of its work is for consumer drug brands.

Cardinal Digital Marketing

Cardinal has a page for pharmaceutical Facebook advertising that describes patient-focused funnel campaigns, creative testing and conversion work (cardinaldigitalmarketing.com). Its specialties directory is mostly healthcare providers, so ask how much of its work is for drug manufacturers.

Network, media agency or focused partner?

The firm type often matters more than the name. Here is how the three groups tend to differ when the job is paid social.

  • Commercialization networks such as Klick, EVERSANA INTOUCH, Fingerpaint and Real Chemistry can cover strategy, creative, medical writing and access. You trade some focus for breadth, and paid social may be a small slice of a large account.
  • Health media agencies such as CMI Media Group, PHM and Underscore plan and buy across channels. They are built to plan and buy across many channels, so they can fit when social has to sit inside a wider media plan.
  • Focused paid social partners such as Be Leaded and Supreme Optimization spend their days inside the platforms. They suit brand teams that already have creative and review in place and want campaigns built and run well.

None of these is better in the abstract. A launch brand with a big budget and a thin internal team may need a network. An established brand with a strong in-house creative group may only need someone to run the platforms. Match the firm to the gap you actually have.

Fair balance and ISI in a social ad

Fair balance comes from FDA's prescription drug advertising regulation. Under 21 CFR 202.1, the rule treats an ad as misleading when what it says about how well a drug works is not balanced against what it says about side effects and contraindications (eCFR, 21 CFR 202.1). In plain terms, the risks cannot be buried while the benefits get the headline.

ISI stands for Important Safety Information. It is the risk content a brand presents with its promotional material, and on social it creates real design problems. A feed ad has a short caption, a small image and a reader who scrolls fast. Your agency has to show where the risk information will appear, how it stays visible and what happens when a format truncates text.

FDA has issued draft guidance on how to show risks and benefits where character space is short, and it keeps an industry page listing its social media guidances (FDA social media guidance for industry). Ask any agency you are considering which of those documents its team works from and how it applies them to each format.

Our guide to pharma advertising regulations on social media goes deeper on the rules, recent FDA actions and the checks to finish before any social ad goes live.

What Meta requires for prescription drug ads

Meta allows ads that promote prescription drugs, but only from eligible advertisers that prove they are licensed. Its Drugs and Pharmaceuticals standard says online pharmacies, telehealth providers and pharmaceutical manufacturers must show they are appropriately licensed or otherwise lawful in the countries they target, and may only run ads in the countries where they are certified. Meta does not allow prescription drug targeting to people under 18 (Meta Advertising Standards, Drugs and Pharmaceuticals).

That has practical effects. Authorization has to be in place before a branded campaign can launch, audiences must be built with age limits and country rules in mind and copy has to avoid implying anything about a person's health. A good agency asks early whether your company is already authorized and plans around the answer.

Meta can change these standards, so treat any summary, including this one, as a starting point. Your team should read the current policy before planning a campaign.

What X requires for health and pharma ads

X restricts the promotion of health and pharmaceutical products and services. Its policy says the rules depend on the product and on the country a campaign targets, and that unless a case is listed, promotion is prohibited. Some listed cases are allowed only with prior authorization from X, which starts with contacting an X account team (X Help Center, Health and pharmaceutical products and services).

The policy covers pharmaceutical manufacturers, prescription and non-prescription drugs, clinical trials and healthcare communications such as disease awareness. In other words, nearly anything a pharma brand would run on X falls under it.

When you talk to agencies, ask who has handled X authorization for a pharma advertiser before, which countries they have run in and how they adapt ISI to X ad formats. Vague answers here are a warning sign.

How an agency should fit into MLR review

Most pharma companies route promotional material through a medical, legal and regulatory review, often shortened to MLR. Reviewers decide what claims can be made, what risk information must appear and how. An agency does not replace that process. Its job is to make review easier.

In practice that means a few habits. The agency should submit complete packages: ad copy, images, landing pages, forms and targeting notes together. It should keep a record of which version was approved and launch only that version. It should never edit live ads without sending the change back through review. And it should plan the number of creative variants around what your reviewers can realistically handle.

Ask each firm to walk you through one review cycle from brief to launch. Listen for who owns each step, how comments are tracked and what the agency does when a platform rejects an approved ad.

Platform approval and MLR approval are separate. An ad your reviewers approve can still be rejected by Meta or X, and an ad a platform accepts has not been cleared by your company. A good partner treats the two as independent checks.

Comments and possible adverse event reports

Paid social invites replies. People comment on drug ads, sometimes to describe their own experience with a medicine. Your company will have rules for spotting and passing on possible adverse event reports, and your agency has to follow them.

Before launch, agree who watches comments, how often, which words trigger an escalation and who in your company receives the report. Decide whether comments will be open, limited or turned off on each placement. Write the process down and test it.

An agency that has not thought about this is not ready for pharma work, whatever its media skills.

Questions to ask before you sign

Use these questions in every pitch. The answers will tell you more than any capabilities deck.

  • Who exactly will plan, build and run our campaigns, and how much of their week goes to our brand?
  • Which platforms do you buy on directly for pharma advertisers, and are we already authorized on each?
  • How do you present ISI and keep fair balance in short feed formats?
  • What does one MLR cycle look like with you, from brief to approved launch?
  • How do you handle comments that might describe a side effect?
  • What reporting will we see, how often and in what form?
  • Can we buy paid social on its own, or only as part of a wider retainer?
  • What happens to our ad accounts, audiences and creative if we part ways?

Write the answers down and compare them side by side. Firms that answer clearly and in specific terms are usually the ones that run clean campaigns.

Patient, caregiver and HCP audiences on social

Pharma paid social rarely has one audience. A single brand may need to reach people living with a condition, the family members who help them manage it and the prescribers who treat them. Each group uses social platforms differently and each brings its own review questions.

Patient and caregiver campaigns usually run on consumer platforms like Facebook, Instagram and X. The hard part is reaching the right people without implying that the ad knows anything about the viewer's health. Copy that says "you have" a condition, or targeting that feels too personal, can break platform rules and erode trust at the same time.

HCP campaigns often lean on professional targeting and on content that reads more like clinical information than a consumer message. Reviewers tend to look closely at how data is presented and which studies are cited. Ask an agency how it separates patient and HCP creative, accounts and reporting so the two never blur.

Unbranded disease awareness work sits in a third lane. It can open doors that branded ads cannot, but it brings its own rules about how and when the product can be linked. Your reviewers will decide where that line falls. A good agency plans the campaign structure around their answer rather than testing the edges.

Red flags in an agency pitch

Most pitches sound alike. These signs suggest a firm is not ready for regulated work, however polished the deck looks.

  • It promises that ads will be approved by a platform or by your reviewers
  • It cannot name who would actually run your account
  • It shows creative with no risk information and calls it a concept
  • It has no plan for comments that mention side effects
  • It wants to own your ad accounts and audiences
  • It treats review as a hurdle to get around instead of part of the work

One flag alone may have an innocent explanation. Two or three together usually do not.

Starting with a contained first program

If you are unsure about a new partner, start small. Pick one campaign type, one audience and one platform. Agree on what success looks like before anything is built and agree on how review will run.

A contained first program lets you judge how the agency handles review, how it communicates and whether its reporting is useful. It also limits the work your reviewers take on while you learn how the agency operates.

If you want to see how we would scope a first program, our pharma paid social page sets out how we plan campaigns around review. For paid social outside pharma, see our paid social and search page.

Sources

All sources were opened on November 17, 2026. More buyer guides are on our guides hub.

Frequently asked questions

What is the best pharma paid social agency?

There is no single best firm for every brand. The right agency is the one that can run campaigns on Meta and X inside your medical, legal and regulatory review. Firms to compare include Be Leaded, Klick Health, EVERSANA INTOUCH, Fingerpaint Group, Real Chemistry and CMI Media Group.

What does a pharma paid social agency do?

It plans audiences, builds ads and landing pages, submits approved versions to platforms like Meta and X, manages budgets and reports on results. In pharma it also has to work inside the brand's review process and follow platform rules for drug ads.

Can pharma brands run prescription drug ads on Meta?

Yes, with conditions. Meta requires pharmaceutical manufacturers to show they are licensed or otherwise lawful in the countries they target, to run ads only where they are certified and not to target people under 18. Read Meta's current Drugs and Pharmaceuticals standard before planning.

Does X allow pharmaceutical ads?

X restricts health and pharmaceutical ads by product and by country. Promotion is prohibited unless a case is listed in its policy, and some cases require prior authorization from X through an X account team.

What is fair balance in a social media ad?

Fair balance means risk information is given comparable weight to benefit information. Under 21 CFR 202.1, a prescription drug ad is treated as misleading when its effectiveness message is not balanced against its side effects and contraindications.

What is ISI in pharma advertising?

ISI stands for Important Safety Information, the risk content a brand presents with promotional material. On social, the agency has to show where ISI appears in each format and how it stays visible when text is shortened.

Who approves pharma social ads before they run?

The brand's medical, legal and regulatory reviewers approve claims, risk information and landing pages. The platform then decides separately whether the ad can run. An agency should launch only the version your reviewers approved.

Should we hire a large network or a focused paid social agency?

Choose a network if you need creative, medical writing and access work from one partner. Choose a focused paid social agency if you already have creative and review in place and want someone to run the platforms well.

Talk to Be Leaded about pharma paid social

Bring your campaign type, your audience, your markets and a picture of how review works at your company. We will tell you plainly whether we fit and what a first program could look like.